News Article
Spironolactone prevents hyperkaleamia in transgender teens
09 Apr 2019

According to data, published in the Journal of the Endocrine Society, only 2.2% of transgender adolescents treated with spironolactone developed hyperkalemia after starting initiation therapy.

Healio